Lexibulin
Lexibulin (CYT-997) is a potent and orally active tubulin polymerisation inhibitor with IC50s of 10-100 nM in cancer cell lines; with potent cytotoxic and vascular disrupting activity in vitro and in vivo[1][2]. Lexibulin induces cell apoptosis and induces mitochondrial ROS generation in GC cells[3].
Product Specifications
CAS Number
917111-44-5
Product Name Alternative
CYT-997
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Microtubule/Tubulin; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Lexibulin.html
Concentration
10mM
Purity
99.10
Solubility
DMSO : ≥ 100 mg/mL
Smiles
CCC[C@H](NC1=C(C)C=NC(C2=CC=C(NC(NCC)=O)C(OC)=C2)=N1)C3=CN=CC=C3
Molecular Formula
C24H30N6O2
Molecular Weight
434.53
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human Tyr-3/Trp- 5 Monooxygenase Activation Protein, Tau
Recombinant Human Tyr-3/Trp- 5 Monooxygenase Activation Protein, Tau
Recombinant Human Tyr-3/Trp- 5 Monooxygenase Activation Protein, Tau
Anti-SARS-CoV-2 Spike glycoprotein antibody (T553)